SCHEMBL8718037

SCHEMBL8718037

CC(=O)N[C@@H]1[C@H](O)[C@@H]2OC(c3ccccc3)OC[C@H]2O[C@@H]1O

nearest known ligand 0.76

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.76
▸ MEN1 O00255 2/20 0.55
▸ L3MBTL1 Q9Y468 3/20 0.54
▸ ALDH1A1 P00352 4/20 0.51
▸ PKM P14618 1/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ MAPT P10636 3/20 0.35
▸ LMNA P02545 2/20 0.35
▸ ATM Q13315 2/20 0.35
▸ MITF O75030 1/20 0.35
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ HK1 P19367 1/20 0.33
▸ HK2 P52789 1/20 0.33
▸ HRAS P01112 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5532821 1.00 KMT2A (0.76) KMT2AMEN1L3MBTL1ALDH1A1PKM
SCHEMBL7570134 1.00 KMT2A (0.76) KMT2AMEN1L3MBTL1ALDH1A1PKM
SCHEMBL2503406 1.00 KMT2A (0.76) KMT2AMEN1L3MBTL1ALDH1A1PKM
SCHEMBL12195138 1.00 KMT2A (0.76) KMT2AMEN1L3MBTL1ALDH1A1PKM
SCHEMBL8584208 0.96 KMT2A (0.70) KMT2AMEN1L3MBTL1ALDH1A1PKM
SCHEMBL18095977 0.91 KMT2A (0.63) KMT2AMEN1L3MBTL1ALDH1A1PKM
SCHEMBL21778853 0.89 KMT2A (0.62) KMT2AMEN1L3MBTL1ALDH1A1PKM
SCHEMBL24236918 0.86 KMT2A (0.69) KMT2AMEN1L3MBTL1ALDH1A1PKM
SCHEMBL7150056 0.86 KMT2A (0.69) KMT2AMEN1L3MBTL1ALDH1A1PKM
SCHEMBL12930889 0.86 KMT2A (0.69) KMT2AMEN1L3MBTL1ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160271199-A1 Taste Modifiers and Therapeutic Methods Thereof Weight Sciences, LLC (US) 2016-09-22 — — US disclosed
EP-0829104-A1 HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS UNISEARCH LIMITED (AU) 1998-03-18 — — EP disclosed
WO-1996035239-A1 HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS UNISEARCH LIMITED (AU) 1996-11-07 — — WO disclosed
US-5466679-A NUCLEOSIDES FOR TREATING TUMOR CELLS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 1995-11-14 — — US disclosed
US-4053591-A 5-DEOXY-4,6-DI-O-(AMINOGLYCOSYL)-1,3-DIAMINOCYCLITOLS, METHODS FOR THEIR MANUFACTURE, METHOD FOR THEIR USE AS ANTIBACTERIAL AGENTS AND COMPOSITIONS USEFUL THEREFOR SCHERING CORPORATION (US) 1977-10-11 — — US disclosed
US-4000262-A 5-EPI-AMINO AND 5-EPI-AZIDO-4,6-DI-O-(AMINOGLYCOSYL)-2,5-DIDEOXYSTREPTAMINES 1-N-ALKYL-5-EPI-AMINO AND 1-N-ALKYL-5-EPI-AZIDO-4,6-DI-O-(AMINOGLYCOSYL)-2,5-DIDEOXYSTREPTAMINES SCHERING CORPORATION (US) 1976-12-28 — — US disclosed
US-4000261-A 5-EPI-4,6-DI-O-(AMINOGLYCOSYL)-2-DEOXYSTREPTAMINES, METHODS FOR THEIR MANUFACTURE AND INTERMEDIATES USEFUL THEREIN, METHODS FOR THEIR USE AS ANTIBACTERIAL AGENTS AND COMPOSITIONS USEFUL THEREFOR SCHERING CORPORATION (US) 1976-12-28 — — US disclosed
Send feedback